"ଉଚ୍ଚ ରକ୍ତଚାପ" ପୃଷ୍ଠାର ସଂସ୍କରଣଗୁଡ଼ିକ ମଧ୍ୟରେ ତଫାତ
Content deleted Content added
→ନିଦାନଶରୀରତତ୍ତ୍ୱ: ରୋଗ ନିର୍ଣ୍ଣୟ ଯୋଗ କରାଗଲା |
→ରୋଗ ନିର୍ଣ୍ଣୟ: ସାରଣୀ ତିଆରି କରାଗଲା |
||
୪୪ କ ଧାଡ଼ି:
ବହିଃସ୍ଥାନୀୟ ପ୍ରତିରୋଧ(Peripheral Resistance)କିପରି ହୁଏ ସେ ବିଷୟରେ ଅନେକ ତଥ୍ୟ ଉପସ୍ଥାପନ କରାଯାଇଛି । ମୂଖ୍ୟତଃ ବୃକକର ରେନିନ-ଆଞ୍ଜିଓଟେନ୍ସିନ୍ ସିସ୍ଟମ<ref>{{cite journal |author=Navar LG |title=Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension |journal=J. Appl. Physiol. |volume=109 |issue=6 |pages=1998–2000; discussion 2015 |year=2010 |month=December |pmid=21148349 |pmc=3006411 |doi=10.1152/japplphysiol.00182.2010a |url=}}</ref> ବା ସିମ୍ପାଥେଟିକ ସ୍ନାୟୁ ମଣ୍ଡଳର କିଛି ପରିବର୍ତ୍ତନ<ref>{{cite journal |author=Esler M, Lambert E, Schlaich M |title=Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension |journal=J. Appl. Physiol. |volume=109 |issue=6 |pages=1996–8; discussion 2016 |year=2010 |month=December |pmid=20185633 |doi=10.1152/japplphysiol.00182.2010 |url=}}</ref> ଯୋଗୁ ଏହା ହୋଇପାରେ । ରକ୍ତନଳୀମାନଙ୍କର କାନ୍ଥର ଭିତର ସ୍ତର ବା ଏଣ୍ଡୋଥେଲିଅମର କ୍ରିୟାର ପରିବର୍ତ୍ତନ ବା ରକ୍ତନଳୀର ପ୍ରଦାହ ଏହି ପ୍ରତିରୋଧର କାରଣ ହୋଇପାରେ ।<ref>{{cite journal |author=Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S |title=Endothelium-dependent contractions and endothelial dysfunction in human hypertension |journal=Br. J. Pharmacol. |volume=157 |issue=4 |pages=527–36 |year=2009 |month=June |pmid=19630832 |pmc=2707964 |doi=10.1111/j.1476-5381.2009.00240.x |url=}}</ref><ref>{{cite journal |author=Marchesi C, Paradis P, Schiffrin EL |title=Role of the renin-angiotensin system in vascular inflammation |journal=Trends Pharmacol. Sci. |volume=29 |issue=7 |pages=367–74 |year=2008 |month=July |pmid=18579222 |doi=10.1016/j.tips.2008.05.003 |url=}}</ref>
== ରୋଗ ନିର୍ଣ୍ଣୟ ==
{| class="wikitable" style = "float: right; margin-left:15px; text-align:center"
|-
|+ ରକ୍ତଚାପ ନିମନ୍ତେ କରାଯାଉଥିବା ପରୀକ୍ଷା
! ମଣ୍ଡଳ
! ପରୀକ୍ଷା
|-
| [[Urinary system|ବୃକକୀୟ]]
| [[Urinalysis|ଅଣୁବୀକ୍ଷଣୀୟ ମୂତ୍ର ପରୀକ୍ଷା]], [[ପରିସ୍ରାରେ ପ୍ରୋଟିନ ବିଶ୍ଳେଷଣ]], [[blood urea nitrogen|ରକ୍ତ ୟୁରିଆ ଯବକ୍ଷାରଜାନ]] ଏବଂ/ବା କ୍ରିଏଟିନ
|-
| [[Endocrine system|ଅନ୍ତସ୍ରାବୀ ଗ୍ରନ୍ଥି]]
| ସେରମ [[ସୋଡିଅମ]], [[ପଟାସିୟମ ]], [[କ୍ୟାଲସିୟମ ]], [[Thyroid-stimulating hormone|ଟି.ଏସ ॰ ଏଚ]]
|-
| [[ମେଟାବୋଲିକ]]
| [[Glucose test|ଫାଷ୍ଟିଙ୍ଗ ରକ୍ତ ଗ୍ଳୁକୋଜ]], [[High-density lipoprotein| ଏଚ ଡି ଏଲ]], [[ଏଲ ଡି ଏଲ]], ସଂପୂର୍ଣ୍ଣ କୋଲେଷ୍ଟେରଲ ଓ [[ଟ୍ରାଇଗ୍ଲିସେରାଇଡ]]
|-
| ଅନ୍ୟାନ୍ୟ
| [[ହେମାଟୋକ୍ରିଟ]], [[ଇଲେକ୍ଟ୍ରୋକାଡିୟୋଗ୍ରାମ]], ଓ [[ଛାତି ଏକ୍ସ-ରେ]]
|-
| colspan=2 | Sources: ''Harrison's principles of internal medicine''<ref name="isbn0-07-147691-1">{{cite book |author=Loscalzo, Joseph; Fauci, Anthony S.; Braunwald, Eugene; Dennis L. Kasper; Hauser, Stephen L; Longo, Dan L. |editor= |others= |title=Harrison's principles of internal medicine |edition= |publisher=McGraw-Hill Medical |year=2008 |pages= |isbn=0-07-147691-1 |doi= |url= |accessdate=}}</ref> ''others''<ref name="pmid19417858">{{cite journal |author=Padwal RS |title=The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk |journal=Canadian Journal of Cardiology |volume=25 |issue=5 |pages=279–86 |year=2009 |month=May |pmid=19417858 |doi= 10.1016/S0828-282X(09)70491-X|url= |pmc=2707176 |author-separator=, |author2=Hemmelgarn BR |author3=Khan NA |display-authors=3 |last4=Grover |first4=S |last5=McKay |first5=DW |last6=Wilson |first6=T |last7=Penner |first7=B |last8=Burgess |first8=E |last9=McAlister |first9=FA}}</ref><ref name="pmid18548142">{{cite journal |author=Padwal RJ |title=The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk |journal=Canadian Journal of Cardiology |volume=24 |issue=6 |pages=455–63 |year=2008 |month=June |pmid=18548142 |pmc=2643189 |doi= 10.1016/S0828-282X(08)70619-6|url= |author-separator=, |author2=Hemmelgarn BR |author3=Khan NA |display-authors=3 |last4=Grover |first4=S |last5=McAlister |first5=FA |last6=McKay |first6=DW |last7=Wilson |first7=T |last8=Penner |first8=B |last9=Burgess |first9=E}}</ref><ref name="pmid17534459">{{cite journal |author=Padwal RS |title=The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 – blood pressure measurement, diagnosis and assessment of risk |journal=Canadian Journal of Cardiology |volume=23 |issue=7 |pages=529–38 |year=2007 |month=May |pmid=17534459 |pmc=2650756 |doi= 10.1016/S0828-282X(07)70797-3|url= |author-separator=, |author2=Hemmelgarn BR |author3=McAlister FA |display-authors=3 |last4=McKay |first4=DW |last5=Grover |first5=S |last6=Wilson |first6=T |last7=Penner |first7=B |last8=Burgess |first8=E |last9=Bolli |first9=P}}</ref><ref name="pmid16755312">{{cite journal |author=Hemmelgarn BR |title=The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I – Blood pressure measurement, diagnosis and assessment of risk |journal=Canadian Journal of Cardiology |volume=22 |issue=7 |pages=573–81 |year=2006 |month=May |pmid=16755312 |pmc=2560864 |doi= 10.1016/S0828-282X(06)70279-3|url= |author-separator=, |author2=McAlister FA |author3=Grover S |display-authors=3 |last4=Myers |first4=MG |last5=McKay |first5=DW |last6=Bolli |first6=P |last7=Abbott |first7=C |last8=Schiffrin |first8=EL |last9=Honos |first9=G}}</ref><ref name="pmid16003448">{{cite journal |author=Hemmelgarn BR |title=The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk |journal=Canadian Journal of Cardiology |volume=21 |issue=8 |pages=645–56 |year=2005 |month=June |pmid=16003448 |doi= |url= |author-separator=, |author2=McAllister FA |author3=Myers MG |display-authors=3 |last4=McKay |first4=DW |last5=Bolli |first5=P |last6=Abbott |first6=C |last7=Schiffrin |first7=EL |last8=Grover |first8=S |last9=Honos |first9=G}}</ref>
|}
== ଆଧାର ==
| |||